Cough Hypersensitivity Syndrome Treatment Market to Grow with a CAGR of 5.14% through 2028
Growing disease burden includes majority of
pediatric population as they have lower immunity level compared to adults are
expected to drive the Global Cough Hypersensitivity Syndrome Treatment Market
growth in the forecast period, 2024-2028.
According to
TechSci Research report, “Cough Hypersensitivity Syndrome Treatment Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the Global Cough Hypersensitivity Syndrome Treatment
Market stood at USD 3.43 Billion in 2022 and is anticipated to grow with a CAGR
of 5.14% through 2028. Cough is a common disease affecting millions of people
worldwide. The rise in the prevalence of chronic respiratory diseases globally
is leading to an increase in chronic cough conditions globally. Thus, the
growing burden of disease offers a promising future for the global market.
Although some studies suggest that the risk of developing cough may be
increased, due to other certain factors, such as asthma, smoking, hot and humid
climate, and viral or bacterial infection. As per the WHO, cough is ranked as
the most prevalent disease globally. Most of the novel products are
reformulated drugs with improvised vehicles or combinatorial therapies. The
treatment algorithm is witnessing a paradigm shift from small molecules towards
natural therapies and biologics. Combination therapies have also been gaining
popularity over the last few years. Most industry-sponsored products are in
clinical trials. In addition, the key players are focusing on making cough
syrup of pleasant taste and easy intake for oral use. The growing disease
burden includes majority of pediatric population as they have lower immunity
level compared to adults. Most pediatric patients prefer liquid as dosage
forms. Growing demand of cough remedies is driven by the presence of routinely
monitored formulations, technological advancement in the field of drug delivery
systems, and increasing awareness amongst patients. However, drug abuse and
dependence on cough hypersensitivity syndrome drugs are the factors that are
expected to restrict the market's growth.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Cough Hypersensitivity Syndrome Treatment Market.”
The Global Cough
Hypersensitivity Syndrome Treatment Market is segmented Drug Class, Distribution
Channel, and company.
Based on the
Drug Class, the Anti-Cholinergics drugs segment is anticipated to witness
substantial market growth throughout the forecast period. The Global Cough
Hypersensitivity Syndrome (CHS) Treatment Market is poised for growth,
propelled by the expanding role of Anti-Cholinergic drugs in addressing the
symptoms of CHS. Anti-Cholinergic medications, which modulate the activity of
acetylcholine, have demonstrated efficacy in managing chronic cough associated
with CHS. These drugs act on the cholinergic pathways implicated in
hypersensitivity, thereby mitigating the exaggerated cough reflex. The
increasing adoption of Anti-Cholinergic drugs is driven by their potential to
provide symptomatic relief, offering a targeted therapeutic approach for
individuals suffering from CHS. As these medications gain prominence in the
treatment landscape, pharmaceutical companies investing in the development and
optimization of Anti-Cholinergic formulations are well-positioned to capitalize
on the growing market demand. Moreover, the positive clinical outcomes
associated with Anti-Cholinergic drugs contribute to a broader acceptance among
healthcare professionals, fostering confidence in their prescription for CHS
patients.
Based on the
Distribution Channel segment, the Retail Pharmacies segment has been the
dominant force in the market. The growth trajectory of the Global Cough
Hypersensitivity Syndrome (CHS) Treatment Market is poised to be significantly
influenced by the pivotal role of retail pharmacies. As accessibility and
convenience become paramount considerations for patients seeking CHS
treatments, retail pharmacies emerge as crucial distribution channels for
pharmaceutical companies. The strategic placement of medications in these
easily accessible outlets ensures a broader reach, facilitating the timely
availability of CHS treatments to a wider patient population. Retail pharmacies
not only serve as convenient points of access for prescription medications but
also contribute to patient education and adherence. Pharmacists, as trusted
healthcare professionals, play a pivotal role in disseminating information,
addressing patient queries, and reinforcing treatment regimens. This engagement
enhances patient understanding and compliance, crucial factors for the
successful management of CHS. Moreover, the retail pharmacy landscape provides
an avenue for effective marketing strategies, creating awareness about CHS
treatments and fostering brand recognition.
Major companies
operating in Global Cough Hypersensitivity Syndrome Treatment Market are:
- Pfizer
Inc.
- GlaxoSmithKline
plc.
- Boehringer
Ingelheim GmbH.
- AstraZeneca
PLC.
- F.
Hoffmann-La Roche Ltd.
- Teva
Pharmaceutical Industries Ltd.
- Novartis
AG.
- Merck
& Co. Inc.
- Vertex
Pharmaceuticals Incorporated.
- Johnson
& Johnson Consumer Inc.
Download Free Sample Report
Customers can
also request 10% free customization on this report.
“Several
collaborative efforts were undertaken by major companies to enhance their
R&D capabilities and ensure high medical standards are anticipated to impel
the demand across this north America region. Moreover, the majority share can
also be attributed to the high disease burden in this north America region.
Increasing cases of cough and rising pediatric population are the key factors
that are driving the market studied in this north America region. Strategic partnerships between pharmaceutical
companies and government organizations are on a rise in the region,
particularly to develop generic drugs and spread awareness amongst healthcare
professionals. Increasing awareness levels and rising focus of healthcare
providers on the eradication of coughing ailments are expected to boost growth
within the region. ” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Cough
Hypersensitivity Syndrome Treatment Market - Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class
(Antitussive Agents, Inhaled Corticosteroids, Short Acting Beta-2 Agonists,
Anti-Cholinergics, Antihistamines, Proton Pump Inhibitors, Others), By
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies), By Region, By Competition”, has evaluated
the future growth potential of Global Cough Hypersensitivity Syndrome Treatment
Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Cough Hypersensitivity Syndrome Treatment Market.
Contact
TechSci
Research LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Contact:
+13322586602
Email:
[email protected]
Web:
https://www.techsciresearch.com